DK1425005T3 - Farmaceutisk sammensætning indeholdende lumiracoxib - Google Patents

Farmaceutisk sammensætning indeholdende lumiracoxib

Info

Publication number
DK1425005T3
DK1425005T3 DK02767455T DK02767455T DK1425005T3 DK 1425005 T3 DK1425005 T3 DK 1425005T3 DK 02767455 T DK02767455 T DK 02767455T DK 02767455 T DK02767455 T DK 02767455T DK 1425005 T3 DK1425005 T3 DK 1425005T3
Authority
DK
Denmark
Prior art keywords
lumiracoxib
pharmaceutical composition
composition containing
pharmaceutical
containing lumiracoxib
Prior art date
Application number
DK02767455T
Other languages
Danish (da)
English (en)
Inventor
Anees Abdulquadar Karnachi
Simon David Bateman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1425005T3 publication Critical patent/DK1425005T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02767455T 2001-08-31 2002-08-30 Farmaceutisk sammensætning indeholdende lumiracoxib DK1425005T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31638901P 2001-08-31 2001-08-31

Publications (1)

Publication Number Publication Date
DK1425005T3 true DK1425005T3 (da) 2006-09-04

Family

ID=23228840

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02767455T DK1425005T3 (da) 2001-08-31 2002-08-30 Farmaceutisk sammensætning indeholdende lumiracoxib

Country Status (30)

Country Link
US (2) US20030114527A1 (el)
EP (1) EP1425005B1 (el)
JP (1) JP4636796B2 (el)
KR (1) KR100895551B1 (el)
CN (1) CN100406008C (el)
AR (1) AR036312A1 (el)
AT (1) ATE324883T1 (el)
AU (1) AU2002331094B2 (el)
BR (1) BR0212155A (el)
CA (1) CA2456604C (el)
CO (1) CO5560554A2 (el)
CY (1) CY1106137T1 (el)
DE (1) DE60211183T2 (el)
DK (1) DK1425005T3 (el)
EC (1) ECSP044986A (el)
ES (1) ES2263813T3 (el)
HK (1) HK1087336A1 (el)
HU (1) HUP0401429A2 (el)
IL (1) IL160375A0 (el)
MX (1) MXPA04001933A (el)
MY (1) MY137516A (el)
NO (1) NO20040860L (el)
NZ (1) NZ531342A (el)
PE (1) PE20030323A1 (el)
PL (1) PL367464A1 (el)
PT (1) PT1425005E (el)
RU (1) RU2329801C2 (el)
SI (1) SI1425005T1 (el)
WO (1) WO2003020261A1 (el)
ZA (1) ZA200400877B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas
GB0201520D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Pharmaceutical uses
CA2476744A1 (en) * 2002-03-07 2003-09-12 Novartis Ag Solid pharmaceutical compositions comprising lumiracoxib
EP2650279A3 (en) 2008-08-19 2014-02-12 XenoPort, Inc. Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
US20140093563A1 (en) * 2011-06-13 2014-04-03 Ranbaxy Laboratories Limited Febuxostat compositions
DK2851075T3 (da) 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
WO2014031844A1 (en) 2012-08-22 2014-02-27 Xenoport, Inc. Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AU2013305684B2 (en) 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
EA018867B1 (ru) * 2012-11-01 2013-11-29 Лаборатория Тютор С.А.С.И.Ф.И.А. Способ получения фармацевтической композиции и продукт способа
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc (n,n-二乙基胺甲醯基)甲基(2e)丁-2-烯-1,4-二酸甲酯之晶形、合成方法及用途
MX368159B (es) * 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028936A1 (en) * 1993-06-08 1994-12-22 Ciba-Geigy Ag Process for the preparation of an oral solid dosage form containing diclofenac
JPH11512754A (ja) * 1996-05-17 1999-11-02 メルク エンド カンパニー インコーポレーテッド シクロオキシゲナーゼ―2媒介疾患の一日一回治療用組成物
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas

Also Published As

Publication number Publication date
EP1425005A1 (en) 2004-06-09
ZA200400877B (en) 2004-11-01
KR20040031019A (ko) 2004-04-09
ATE324883T1 (de) 2006-06-15
US20070231382A1 (en) 2007-10-04
AU2002331094B2 (en) 2006-08-31
SI1425005T1 (sl) 2006-12-31
NZ531342A (en) 2005-09-30
CN100406008C (zh) 2008-07-30
CN1728993A (zh) 2006-02-01
HK1087336A1 (en) 2006-10-13
IL160375A0 (en) 2004-07-25
US20030114527A1 (en) 2003-06-19
PL367464A1 (en) 2005-02-21
MY137516A (en) 2009-02-27
KR100895551B1 (ko) 2009-04-29
EP1425005B1 (en) 2006-05-03
ES2263813T3 (es) 2006-12-16
PT1425005E (pt) 2006-09-29
DE60211183T2 (de) 2007-02-01
PE20030323A1 (es) 2003-05-12
DE60211183D1 (de) 2006-06-08
CY1106137T1 (el) 2011-06-08
RU2329801C2 (ru) 2008-07-27
JP4636796B2 (ja) 2011-02-23
AR036312A1 (es) 2004-08-25
BR0212155A (pt) 2004-07-13
RU2004109920A (ru) 2005-04-20
ECSP044986A (es) 2004-04-28
WO2003020261A1 (en) 2003-03-13
MXPA04001933A (es) 2004-06-15
CA2456604A1 (en) 2003-03-13
NO20040860L (no) 2004-04-22
CA2456604C (en) 2011-02-08
CO5560554A2 (es) 2005-09-30
JP2005520785A (ja) 2005-07-14
HUP0401429A2 (hu) 2004-11-29

Similar Documents

Publication Publication Date Title
FI20011478A0 (fi) Farmaseuttinen koostumus
DK1524266T3 (da) Farmaceutisk sammensætning
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
FR2824267B1 (fr) Composition cosmetique filmogene
EE200300416A (et) Ravimvorm
DK1395242T3 (da) Flydende farmaceutisk sammensætning
EE05020B1 (et) Glburiidi ravimkoostis
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
IS7051A (is) Lyfjasamsetningar
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib
EP1408896A4 (en) PHARMACEUTICAL COMPOSITION
FI20022128A (fi) Farmaseuttinen koostumus
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
FR2819176B1 (fr) Composition cosmetique pelable
PL370037A1 (en) Pharmaceutical composition
FR2830751B1 (fr) Composition cosmetique filmogene
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger
IL157411A0 (en) Pharmaceutical composition
SE0100847D0 (sv) Novel pharmaceutical composition